A118G SNP variant
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (12)
Papers in which this entity is mentioned.
- Genetics of substance use disorders in the era of big data. (2021)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. (2017)
- Pharmacogenetics of OPRM1. (2014)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
- Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. (2013)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
- Expansion of the human mu-opioid receptor gene architecture: novel functional variants. (2009)
- Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. (2009)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| a118g | variant | 12 | 50 |
| a118g snp | variant | 2 | 2 |